Verisk Analytics
VRSK
168.68
+3.48
+2.11%
Verisk Analytics
US · VRSK
#867 by market cap
Listed 1970
168.68
+3.48
+2.11%
Live - 5344 symbols - heartbeat 544s ago
· 2026-10-08 07:40
Pre-market
168.68
0.00%
After-hours
168.68
0.00%
Overnight
168.68
0.00%
- Market cap
- 21.95B
- P/E (TTM)i
- 25.91
- P/Bi
- -18.47
- EPSi
- 6.48
- Div yieldi
- 1.13%
- 52W posi
- 15%
Reader sentiment
Are you bullish or bearish on VRSK?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 5.30, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +6.63% YoY
Margins
- Gross margin
- 69.88%
- Operating margin
- 43.74%
- Net margin
- 29.56%
Key ratios & quality
- Enterprise valuei
- 24.53B
- Altman Z-Scorei
- 5.30
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.40B | 2.61B | 2.27B | 2.46B | 2.50B | 2.68B | 2.88B | 3.07B |
| Gross profit | 1.51B | 1.63B | 1.48B | 1.61B | 1.67B | 1.80B | 1.98B | 2.15B |
| Selling & admin expenses | 378.70M | 603.50M | 308.20M | 313.20M | 381.50M | 391.80M | 408.70M | 458.20M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 834.10M | 696.90M | 956.30M | 911.40M | 1.41B | 1.13B | 1.25B | 1.34B |
| Pretax profit | 719.70M | 568.40M | 818.40M | 786.50M | 1.26B | 1.03B | 1.23B | 1.17B |
| Tax | 121.00M | 118.50M | 164.60M | 179.40M | 220.30M | 258.80M | 277.90M | 263.00M |
| Net profit | 598.70M | 449.90M | 712.70M | 666.30M | 954.30M | 614.40M | 957.50M | 908.30M |
| Basic EPS | 4 | 3 | 4 | 4 | 6 | 4 | 7 | 7 |
| Diluted EPS | 3.56 | 2.70 | 4.31 | 4.08 | 6.00 | 4.17 | 6.71 | 6.48 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 753.00M | 772.60M | 768.30M | 778.80M | 782.60M | 806.30M |
| Gross profit | 522.20M | 543.10M | 538.80M | 543.10M | 546.00M | 572.90M |
| Selling & admin expenses | 108.90M | 106.50M | 110.60M | 132.20M | 109.50M | 128.60M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 330.10M | 354.30M | 345.90M | 313.60M | 352.20M | 363.70M |
| Pretax profit | 296.40M | 327.90M | 302.10M | 244.90M | 308.50M | 303.40M |
| Tax | 64.10M | 74.60M | 76.60M | 47.70M | 74.30M | 74.80M |
| Net profit | 232.30M | 253.30M | 225.50M | 197.20M | 234.20M | 228.60M |
| Basic EPS | 2 | 2 | 2 | 1 | 2 | 2 |
| Diluted EPS | 1.65 | 1.81 | 1.61 | 1.42 | 1.73 | 1.75 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 644.50M | 744.90M | 794.20M | 907.40M | 925.10M | 810.10M | 911.60M | 2.77B |
| Cash & ST investments | 139.50M | 184.60M | 218.80M | 111.90M | 112.50M | 302.70M | 291.20M | 2.18B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 5.90B | 7.06B | 7.56B | 7.81B | 6.96B | 4.37B | 4.26B | 6.20B |
| Total current liabilities | 1.32B | 1.49B | 1.43B | 1.85B | 2.32B | 771.40M | 1.24B | 2.30B |
| Short-term debt | 672.80M | 540.00M | 553.00M | 1.00B | 1.42B | 47.60M | 540.20M | 1.54B |
| Long-term debt | 2.03B | 2.65B | 2.69B | 2.34B | 2.34B | 2.83B | 2.52B | 3.21B |
| Total liabilities | 3,829,700,000.00 | 4,794,400,000.00 | 4,863,600,000.00 | 4,965,600,000.00 | 5,193,400,000.00 | 4,043,900,000.00 | 4,159,700,000.00 | 5,885,700,000.00 |
| Total equity | 2.07B | 2.26B | 2.70B | 2.84B | 1.77B | 322.20M | 105.00M | 309.80M |
| Retained earnings | 3.94B | 4.23B | 4.76B | 5.24B | 6.00B | 6.42B | 7.15B | 7.81B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.77B | 1.38B | 2.70B | 2.77B | 1.20B | 1.12B |
| Cash & ST investments | 1.11B | 628.70M | 2.11B | 2.18B | 524.50M | 551.40M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 5.12B | 4.79B | 6.24B | 6.20B | 4.60B | 4.50B |
| Total current liabilities | 1.40B | 899.40M | 2.26B | 2.30B | 1.18B | 1.12B |
| Short-term debt | 546.90M | 44.80M | 1.52B | 1.54B | 283.30M | 282.80M |
| Long-term debt | 3.21B | 3.21B | 3.21B | 3.21B | 4.20B | 4.21B |
| Total liabilities | 4,998,300,000.00 | 4,482,300,000.00 | 5,864,400,000.00 | 5,885,700,000.00 | 5,765,300,000.00 | 5,684,900,000.00 |
| Total equity | 123.80M | 312.60M | 377.50M | 309.80M | -1.17B | -1.19B |
| Retained earnings | 7.32B | 7.51B | 7.68B | 7.81B | 7.98B | 8.14B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 934.40M | 956.30M | 1.07B | 1.16B | 1.06B | 1.06B | 1.14B | 1.44B |
| Depreciation & amortization | 296.10M | 323.70M | 358.10M | 383.60M | 340.00M | 281.40M | 305.90M | 326.70M |
| Free cash flow | 703.40M | 739.50M | 821.40M | 887.30M | 784.30M | 830.70M | 920.10M | 1.19B |
| Dividends paid | 0 | -163.50M | -175.80M | -188.20M | -195.20M | -196.80M | -221.30M | -251.10M |
| Stock buybacks / issuance | -438.60M | -300.00M | -348.80M | -475.00M | -1.66B | -2.80B | -1.05B | -624.00M |
| Ending cash balance | 139.50M | 184.60M | 218.80M | 280.30M | 292.70M | 302.70M | 291.20M | 2.18B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 444.70M | 244.50M | 403.50M | 343.30M | 390.40M | 366.00M |
| Depreciation & amortization | 83.20M | 82.30M | 82.30M | 78.90M | 84.30M | 80.60M |
| Free cash flow | 391.00M | 188.70M | 336.10M | 276.10M | 326.40M | 297.90M |
| Dividends paid | -63.00M | -63.00M | -62.60M | -62.50M | -65.50M | -65.40M |
| Stock buybacks / issuance | -200.10M | -100.00M | -100.10M | -223.80M | -1.63B | -200.10M |
| Ending cash balance | 1.11B | 628.70M | 2.11B | 2.18B | 524.50M | 551.40M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 29.97 | 20.77 | 28.74 | 24.16 | 41.78 | 59.67 | 466.96 | 444.05 |
| ROA %i | 10.04 | 6.95 | 9.75 | 8.67 | 12.92 | 10.85 | 22.19 | 17.37 |
| ROIC %i | 14.53 | 10.53 | 13.84 | 12.06 | 17.61 | 15.38 | 31.22 | 24.33 |
| 5-year avg ROE %i | 55.47 | 38.53 | 31.46 | 27.55 | 29.09 | 35.03 | 124.27 | 207.33 |
| EBIT margin %i | 35.46 | 26.67 | 37.19 | 33.43 | 56.12 | 42.62 | 46.96 | 43.68 |
| FCF / sales %i | 29.37 | 28.36 | 29.50 | 29.59 | 31.41 | 30.98 | 31.93 | 38.79 |
| Current ratioi | 0.49 | 0.50 | 0.56 | 0.49 | 0.40 | 1.05 | 0.74 | 1.20 |
| Quick ratioi | 0.40 | 0.44 | 0.47 | 0.25 | 0.19 | 0.86 | 0.65 | 1.15 |
| Debt / assetsi | 46.16 | 48.19 | 46.61 | 45.81 | 56.82 | 70.90 | 76.11 | 79.10 |
| LT debt / equityi | 99.03 | 126.49 | 110.12 | 91.39 | 144.81 | 983.16 | 2,702.90 | 1,089.06 |
| Interest coveragei | 6.55 | 5.48 | 7.49 | 7.89 | 10.10 | 9.89 | 10.86 | 7.85 |
| Revenue CAGR (3Y) %i | 10.80 | 9.33 | 1.89 | 0.93 | -1.43 | 5.72 | 5.38 | 7.16 |
| Net income CAGR (3Y) %i | 5.66 | -8.70 | 8.69 | 3.63 | 28.49 | -4.83 | 12.85 | -1.63 |
| FCF CAGR (3Y) %i | 12.22 | 20.66 | 13.62 | 8.05 | 1.98 | 0.38 | 1.22 | 14.97 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 478.87 | 246.87 | 272.48 | 444.05 | -- | -- |
| ROA %i | 20.17 | 19.16 | 17.05 | 17.37 | 18.73 | 19.06 |
| ROIC %i | 28.81 | 27.40 | 23.45 | 24.33 | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 47.15 | 44.30 | 44.56 | 43.68 | 43.88 | 43.18 |
| FCF / sales %i | 33.92 | 34.17 | 36.83 | 38.79 | 36.34 | 39.43 |
| Current ratioi | 1.27 | 1.53 | 1.19 | 1.20 | 1.02 | 1.01 |
| Quick ratioi | 1.20 | 1.41 | 1.14 | 1.15 | 0.91 | 0.90 |
| Debt / assetsi | 76.83 | 71.49 | 78.32 | 79.10 | 100.58 | 102.70 |
| LT debt / equityi | 2,754.72 | 1,085.34 | 895.46 | 1,089.06 | -- | -- |
| Interest coveragei | 10.47 | 9.56 | 9.09 | 7.85 | 7.66 | 6.94 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Insurance100.00%
Quote time 2026-10-08 07:40:06 · For reference only, not investment advice and not tailored to your situation.